Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Keith Berend

Adult Reconstructive Orthopaedic Surgery New Albany, OH Medical Doctor

NPI 1003809484 CMS profile 272272

7277 Smiths Mill Rd Ste 200, New Albany, OH 43054

Open in the dashboard

General payments

$4,594,581

209 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$1,358,576

7 holdings reported · through program year 2025

Research they led as principal investigator

$311,607 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Keith Berend of New Albany, OH is reported in the CMS Open Payments database as having received $4,594,581 across 209 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $311,607 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,358,576 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,815 6
2024 General $269,147 44
2023 General $71,180 13
2022 General $53,832 25
2021 General $2,299,464 22
2020 General $841,433 22
2019 General $982,709 77
2025 Ownership $150,953 1
2024 Ownership $150,953 1
2023 Ownership $150,953 1
2022 Ownership $150,953 1
2021 Ownership $150,953 1
2020 Ownership $301,906 1
2019 Ownership $301,906 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keith Berend
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Keith Berend were reported at $76,815. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Keith Berend Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $982,709 $1,416 $292–$9,336 $163
2020 $841,433 $647 $141–$6,474 $114
2021 $2,299,464 $1,073 $211–$6,497 $132
2022 $53,832 $1,217 $236–$6,299 $149
2023 $71,180 $1,082 $246–$6,818 $160
2024 $269,147 $1,575 $323–$8,944 $164
2025 $76,815 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $4,120,686 110 payments
  2. Medacta USA, Inc. $416,736 62 payments
  3. Smith+Nephew, Inc. $42,542 17 payments
  4. Cardinal Health 200, LLC $11,550 2 payments
  5. Engage Uni, LLC $1,614 2 payments
  6. Total Joint Orthopedics, Inc. $1,147 8 payments
  7. Becton, Dickinson and Company $147 1 payment
  8. Davol Inc. $95 3 payments
  9. Ethicon US, LLC $20 1 payment
  10. SI-BONE, Inc. $18 1 payment
  11. Other $26 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $4,025,000 20 payments
  2. Consulting Fee $517,550 55 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,013 3 payments
  4. Travel and Lodging $14,336 47 payments
  5. Food and Beverage $5,700 81 payments
  6. Education $3,868 2 payments
  7. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. Oxford-Knees Knees $2,297,483 13 payments
  2. Arcos Hips $2,275,518 1 payment
  3. Persona $1,679,961 11 payments
  4. Taperloc $1,676,961 8 payments
  5. Vanguard $1,676,961 8 payments
  6. Trabecular Metal (TM) $1,676,961 8 payments
  7. Oxford $966,864 35 payments
  8. Oxford-Knees Knees $840,554 17 payments
  9. GMK Sphere Revision System $254,210 38 payments
  10. Arcos Hips $74,921 12 payments
  11. Other $329,992 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Orthopaedic Surgery: 30

Drug cost

$31

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 18 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

209 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record